Comparative Benchmarking
In the context of the broader market, RVPH competes directly with industry leaders such as LEXX and NNVC. With a market capitalization of $16.42M, it holds a significant position in the sector. When comparing efficiency, RVPH's gross margin of N/A stands against LEXX's N/A and NNVC's N/A. Such benchmarking helps identify whether Reviva Pharmaceuticals Holdings Inc is trading at a premium or discount relative to its financial performance.
